Drug profile · INN
avelumab
BAVENCIO
avelumab (BAVENCIO) is a programmed cell death 1 ligand 1 other. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: injection. Current US regulatory status: approved.
Drug details — avelumab
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- INJECTION
- Patents
- 6
- Programs
- 25
- Data quality
- 0.84
Quick answer
avelumab (BAVENCIO) is a programmed cell death 1 ligand 1 other. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Programmed cell death 1 ligand 1 other
Primary target: Programmed cell death 1 ligand 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
| PMDA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
-
US 11534488
Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability
granted -
US 10800853
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 10385136
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 9790271
Methods for increasing immunoglobulin A levels
granted -
US 9598495
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 9249227
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted
Frequently asked questions
What is avelumab?
avelumab (BAVENCIO) is a programmed cell death 1 ligand 1 other. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for avelumab?
BAVENCIO is a marketed brand name for avelumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of avelumab?
avelumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.